Premium 20mg/ml Hyaluronic Acid Dermal Filler for Facial Volume Restoration | OEM Available for US Market
May 15, 2026
Introduction: Next-Generation Dermal Filler Now Available for the US Aesthetic Market
Jinan Fushunchang International Trade Co., Ltd. (Fosyderm), an established manufacturer and exporter of professional aesthetic products since 2005, announces the availability of its premium 20mg/ml Hyaluronic Acid Dermal Filler for the United States market. This advanced injectable gel is specifically formulated for facial volume restoration, wrinkle reduction, and lip enhancement, meeting the rigorous quality standards expected by US board-certified dermatologists and aesthetic practitioners.
With over two decades of manufacturing expertise and an export portfolio spanning 90% of total production, Fosyderm has built a reputation for delivering high-quality, competitively priced dermal fillers. The company's 20mg/ml Hyaluronic Acid formulation features cross-linked HA technology that provides lasting results of approximately 9–12 months, making it a cost-effective choice for aesthetic clinics across the United States.
Product Specifications and Clinical Advantages
The HA Dermal Filler is available in three specialized models — ultra3, ultra4, and voluma — each engineered for specific treatment depths and facial zones. Ultra3 and ultra4 are optimized for medium to deep wrinkle correction, including nasolabial folds, marionette lines, and perioral rhytids. Voluma is designed for mid-face volumization, restoring cheek contour and providing structural lift comparable to leading FDA-cleared products on the market.
Key product specifications include:
- Concentration: 20mg/ml cross-linked Hyaluronic Acid
- Duration of Effect: Approximately 9–12 months
- Recovery Time: 1–2 days with minimal downtime
- Side Effects: No significant adverse effects when administered per protocol
- OEM Services: Full OEM/private label manufacturing available for US distributors
- Packaging: Two prefilled syringes with four sterile BD needles per box
Market Positioning and US Aesthetic Industry Alignment
According to the American Society of Plastic Surgeons (ASPS), hyaluronic acid fillers remain the second most popular minimally invasive cosmetic procedure in the United States, with over 2.6 million treatments performed annually. Fosyderm's 20mg/ml formulation is positioned to serve this growing demand by offering US clinics a reliable, high-purity injectable at a competitive price point of USD $50–$55 per box.
The product's biocompatibility profile — utilizing cross-linked HA, a substance naturally occurring in human skin — ensures smooth tissue integration and a low immunogenic risk profile. This aligns with the safety expectations of FDA-regulated aesthetic practices and the clinical preferences of US injectors who prioritize predictable rheological properties and consistent gel cohesion.
Quality Assurance and Manufacturing Excellence
| Parameter | Specification |
|---|---|
| Manufacturing Facility | ISO-certified, China |
| Brand | Juvederm Cross-linked HA (Fosyderm OEM) |
| Supply Capacity | 5,000 units per week |
| Minimum Order | 1 box |
| Delivery Time | 5–7 days (international shipping) |
| Payment Terms | L/C, D/A, D/P, T/T, Western Union |
Fosyderm operates an 80–100 person manufacturing facility with dedicated QA/QC protocols. Each batch undergoes sterility testing and endotoxin analysis prior to release. The company's annual export revenue of $300,000–$450,000 reflects growing international confidence in its product portfolio across North America, Europe, and Asia-Pacific regions.
OEM Partnership Opportunities for US Distributors
A key differentiator of Fosyderm's offering is its flexible OEM manufacturing program. US-based medical aesthetics distributors and group purchasing organizations (GPOs) can leverage private-label manufacturing to build proprietary brand portfolios without the capital expenditure of owning production facilities. Fosyderm supports custom packaging, branding, and formulation adjustments to meet specific market positioning requirements within the competitive US injectables landscape.
With minimum order quantities starting at just one box and rapid 5–7 day delivery, the barrier to entry for US clinics and distributors is exceptionally low. This accessibility, combined with the product's clinical performance and safety profile, positions Fosyderm as a strategic partner for US aesthetic businesses seeking to expand their injectable offerings.
About Jinan Fushunchang International Trade Co., Ltd.
Established in 2005 and headquartered in Jinan, China, Jinan Fushunchang International Trade Co., Ltd. (brand: Fosyderm) is a dual-role manufacturer and trading company specializing in professional aesthetic injectables. With 80–100 employees, the company dedicates 90%–100% of its production to international markets, serving aesthetic clinics, distributors, and medical professionals worldwide. The company's core philosophy — "Natural Beauty Starts From Fosyderm Hyaluronic Acid" — reflects its commitment to enhancing natural aesthetics through scientifically advanced, biocompatible dermal filler technologies.